Clinical Trials Logo

Keratoconjunctivitis Sicca clinical trials

View clinical trials related to Keratoconjunctivitis Sicca.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT04884217 Enrolling by invitation - Dry Eye Syndrome Clinical Trials

Treatment of Dry Eye Disease Using Pro-ocularâ„¢ - A Proof of Concept, Safety, and Efficacy Study

Start date: May 20, 2021
Phase: Phase 2
Study type: Interventional

To evaluate the safety and efficacy of 1% Pro-ocular topical gel administered twice daily for 12 weeks in treatment of Dry Eye Disease

NCT ID: NCT04458012 Enrolling by invitation - Dry Eye Clinical Trials

Epidemiological Study of Dry Eye Disease in Stavanger: Dry Eye Disease in Patients Treated With Intravitreal Injections

EPISTA1
Start date: June 25, 2020
Phase:
Study type: Observational

To investigate prevalence of dry eye disease in Norwegian patients with age-related macular degeneration receiving intravitreal injections, as well as to reveal possible risk factors of DED in this population.

NCT ID: NCT04421300 Enrolling by invitation - Dry Eye Clinical Trials

A Randomized Study of Smile Exercise for Dry Eye

Start date: July 2, 2020
Phase: N/A
Study type: Interventional

The objective of the study is to evaluate the effectiveness of laughter therapy in relieving the symptoms of dry eye disease.

NCT ID: NCT03436576 Enrolling by invitation - Dry Eye Clinical Trials

Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye

Start date: September 12, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the effects of autologous serum 20% and autologous serum 50% for the treatment of Severe Dry Eye Syndrome

NCT ID: NCT02774707 Enrolling by invitation - Dry Eye Syndrome Clinical Trials

Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome

Start date: January 2016
Phase: N/A
Study type: Observational

Human autologous serum is commonly used in the treatment of dry eye disease. However, different patients may have different effect with autologous serum treatment. We would like to find if different autologous serum had different component of cytokines in different etiologies of dry eye.

NCT ID: NCT02153515 Enrolling by invitation - Dry Eyes Clinical Trials

Treating Dry Eyes and Corneal Ulcers With Fingerprick Autologous Blood

FAB
Start date: April 2014
Phase: Phase 3
Study type: Interventional

To investigate if fresh finger prick autologous blood (FAB) instead of serum from venesection, is a safe and effective treatment for dry eyes and corneal ulcers/ epithelial defects. Currently there are no studies on the use of whole fresh blood for the treatment of chronic ulcers, persistent epithelial defects or dry eyes. Unpublished case reports indicate that fresh blood can be an effective tool to the treatment of corneal pathology.

NCT ID: NCT00848198 Enrolling by invitation - Dry Eye Disease Clinical Trials

TearLab Core Validation Study

CVS
Start date: February 2009
Phase: N/A
Study type: Observational

This is a global study of tear osmolarity using the OcuSense TearLab technology to compare tear samples of age and sex-matched normals with those with Dry Eye Disease (DED). Diagnosis of DED subjects will be established using objective and subjective tests. Positive responses to 3 out of 6 defined criteria determine subjects with DED. DED subjects will be further categorized by severity, using results from the objective and subjective tests. Subjects will be assessed at a single visit.